MIRA Pharmaceuticals, Inc. Cash and Cash Equivalents
MIRA Pharmaceuticals, Inc. (MIRA) had Cash and Cash Equivalents of $3.61 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-12
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $3.61M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $4.82M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $6.35M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $2.64M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $3.61M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $4.82M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $6.35M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $2.64M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $730.48K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $1.21M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $2.83M 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |